In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side effects.

The term has been popularized on social media to describe numbness and low motivation. Experts offer ways to break out of these feelings.

The shift would mean fewer shots recommended for children. But a Danish health official found the idea baffling, saying the United States was getting “crazier and crazier in public health.”

The companies agreed to sell most of their drugs to Medicaid at the prices they charge in European countries and to sell drugs directly to consumers through a planned TrumpRx website.

Moving cannabis to a category of drugs that includes some common medicines will have implications for research, businesses and patients.

The agency’s high-level turnover and conflicting policy decisions on drug oversight have fueled concerns about the leadership of Dr. Marty Makary.

Proposed new rules would pull all federal financing from hospitals that continue to provide gender treatments for adolescents.

Familial feuds have ripple effects, experts say.

The American Academy of Pediatrics had called the department’s policies “irresponsible and purposefully misleading” and joined a lawsuit against its vaccine policy.